Healthtech Startups
16,921 companies tagged Healthtech, with their investors and founders.
Quadria Capital is a healthcare-focused private equity firm with over $4 billion in assets under management, investing in healthcare businesses across South Asia and Southeast Asia to build regional leaders and drive social impact.
2 investors
Qualifacts provides electronic health record (EHR) and practice management software for behavioral health, substance use disorder, and human services providers in the U.S. It offers three platforms—Credible, CareLogic, and InSync—supporting clinical documentation, scheduling, ePrescribing, billing, analytics, and reporting for organizations ranging from small practices to large enterprise agencies.
2 investors
QualisureDx develops diagnostic tests using machine-learning and molecular analysis to identify unique cancer properties and guide personalized treatment decisions for oncologists. The company serves cancer care teams seeking to match patients with appropriate therapies that maximize efficacy while minimizing toxicity.
2 investors
Quan is a digital platform that assesses individual well-being across dozens of dimensions spanning personal and work life, then aggregates anonymous team-level data to help managers and organizations identify targeted interventions. The platform serves organizations seeking to prevent burnout and embed well-being into business operations.
2 investors
Quantum Health provides healthcare navigation and care coordination for employees and their families, engaging members early in a care journey and guiding them to cost-effective in-network care. It serves employers as a benefits partner, aiming to improve member experiences while reducing claims costs.
2 investors
Quell develops fitness gaming software that combines combat-based gameplay with physical exercise, helping users achieve fitness goals through interactive gaming experiences.
2 investors
QUE Oncology develops Q-122, a non-hormonal therapeutic candidate in clinical development for treating vasomotor symptoms in postmenopausal women and cancer patients on hormone therapy. The company was formed as a joint venture between Emory University and University of Queensland's commercialization entity.
2 investors
Quill Bills automates revenue cycle management for independent healthcare practices, handling insurance claims processing, eligibility verification, denial management, and patient billing through AI agents and EHR integration. The platform reduces manual work in coding, claim submission, payment posting, and collections.
2 investors
Quire provides custom AI, data science, and software development services, including automated clinical note summarization and predictive models for patient readmissions. It serves healthcare organizations and other industries, offering data management, cloud computing, and analytics consulting.
2 investors
Pelago provides virtual-first substance use treatment for tobacco, alcohol, opioids, cannabis, and stimulants, combining digital tools, live counseling, and medication-assisted treatment for employers and organizations.
2 investors
Qurcan develops veterinary pharmaceutical technology, with leadership holding advanced degrees in veterinary medicine, pharmaceutical sciences, and business development.
2 investors
Qure.ai builds deep learning and AI software to detect and manage diseases such as lung cancer, tuberculosis, pediatric TB, and stroke, with several FDA-cleared solutions. It serves clinicians and care teams as well as the pharmaceutical and medical device industries worldwide.
2 investors
Qvin develops the Q-Pad, an FDA-cleared diagnostic menstrual pad that collects menstrual blood samples for non-invasive health monitoring and disease diagnosis. The company uses biomarker analysis from menstrual fluid to serve healthcare organizations and diagnostic platforms in women's health diagnostics.
2 investors
Radformation develops automation software for radiation oncology, including tools for deep-learning contouring, treatment planning, plan evaluation, independent calculations, treatment monitoring, billing QA, and machine QA. Its products integrate with Eclipse TPS and serve cancer clinics and medical physicists to improve plan quality, safety, and workflow efficiency.
2 investors
Radialis develops the Radialis PET Imager, an organ-targeted positron emission tomography system for high-resolution medical imaging of specific tissues and organs. The system is designed for use by healthcare providers in clinical settings to support cancer detection, treatment planning, and precision medicine applications.
2 investors
Radianse provides IoT and cloud-based software solutions for fitness centers to monitor facility operations, track equipment and amenities, and optimize member experience through real-time data and occupancy insights.
2 investors
RADiCAIT develops Insilico PET, an AI-powered technology that transforms routine CT scans into functional disease activity maps without requiring radioactive tracers or additional hardware, enabling faster and more accessible diagnostic imaging at scale.
2 investors
Radiology Partners is a physician-led national radiology practice that provides diagnostic imaging services and develops AI tools and technology to support radiologists in delivering patient care. It serves patients, referring physicians, and healthcare clients across the United States.
2 investors
RadioNano Therapeutics develops boron neutron capture therapy (BNCT), an advanced radiotherapy targeting cancer cells. The company is commercializing RN-501, a nanoparticle-enhanced therapeutic drug aimed at improving treatment safety and efficacy for cancer patients.
2 investors
RapidPulse Medical is an investor relations page showcasing multiple healthcare-focused investment firms and incubators that back medical device and healthcare technology companies.
2 investors
Rapport is a biopharmaceutical company developing novel therapeutics. The company is led by a team with extensive experience in drug discovery, clinical development, and commercialization across neuroscience and rare disease indications.
2 investors
RareCan provides cancer treatment and clinical trial access tailored to individual patients, with a focus on improving outcomes for people diagnosed with rare cancers.
2 investors
Rarity Bioscience develops superRCA, a molecular detection technology that identifies DNA mutations with exceptional sensitivity for precision medicine applications. The company commercializes diagnostic assays and kits for clinical and research settings, with initial focus on leukemia and cancer detection.
2 investors
RayIoT builds an AI-powered respiratory monitoring product using acoustic technology and machine learning to detect breathing variations and conditions like asthma, sleep apnea, and fever in healthcare and wellness settings. The product has been clinically validated in neonatal ICUs with 98% accuracy against medical devices.
2 investors